2300
H. Naito et al. / Tetrahedron Letters 49 (2008) 2298–2301
respectively (see the equation in Table 1). A reaction period
as short as 0.5 h is satisfactory (cf. entries 5 and 6), but
longer times, up to 7 h, were generally used to ensure the
completion of the reaction. Bromopropynamide 9 is a
better acetylenic substrate than the corresponding ethyl
ester 14 (entry 7). With this combination of substrates
and reaction conditions, the desired product 13 was
obtained in 70% yield. Under similar reaction conditions,
other propynamides 16–18 afforded the desired products
19–21 in good yields (entries 8–10).7
Ts
N
K PO
3
4
NHTs
(2 equiv)
+
Br
CONEt
2
DMF, 110 °C
3 h
O
CONEt
2
OH
(34)
89%, single isomer
(33)
(9)
Scheme 4.
olefinic stereochemistry was assigned as Z by a NOESY
experiment.10
Although the tosyl protection of the diamine, such as in
12, proved to be essential for the success of the reaction, we
found that both tosyl groups in 12 are not necessary. Thus,
a mono-tosylated diamine having another protective group
still effected the desired reaction. For instance, Ts- and
Boc-protected diamine 22 afforded the desired product 23
in a satisfactory yield and, surprisingly, as a single stereo-
isomer (Table 1, entry 11). The stereochemistry of its olefin
moiety was assigned as E by a NOESY experiment that
showed the correlation between the vinyl proton and
ortho-protons of the Ts group. Similarly, unsymmetrical
imidazolidines 24–26 were prepared from the correspond-
ing bromoacetylenic amides 16–18 (entries 12–14).7,8
This reaction should proceed according to Scheme 3.
The sulfonamide moiety of 27, under any condition, takes
part in the first conjugate addition/elimination sequence to
produce b-(sulfonylamino)propynamide 28. The second
intramolecular addition of another amido group in 28
forms enolate 29–31, protonation of which most likely
determines the stereochemistry of the product to produce
sterically less hindered 32 (X = Boc).
In summary, 2-alkylidene-1,3-imidazolidines were con-
veniently prepared from suitably protected 1,2-diamines
and bromoproynamides. Further investigation of synthetic
applications of this reaction and its products is now under
way.
Acknowledgments
The authors are grateful to Kyowa Hakko Kogyo Co.,
Ltd for financial support. This work was also supported
in part by a Grant-in-Aid for Young scientists (Start-up)
(No. 18890069) to T.H. from Japan Society for the promo-
tion of science.
References and notes
1. For reviews on imidazolidines of structure 3, see: (a) Wang, M.;
Huang, Z. Prog. Nat. Sci. 2002, 12, 249–257; (b) Huang, Z.-T.; Wang,
M.-X. Heterocycles 1994, 37, 1233–1262. For reviews on imidazoli-
dines, see: (c) Huang, Z.-T.; Wang, M.-X. In The Chemistry of
Enamies; Rappoport, Z., Ed.; Wiley Interscience: London, 1994; pp
1303–1363; (d) Katritzky, A. R., Rees, C. W., Eds. Comprehensive
Heterocyclic Chemistry; Pergamon Press: Oxford, 1984; Vol. 5.
2. Tikhomirov, D. A.; Slyadevskaya, O. S.; Eremeev, A. V. Khim.
Geterotsikl. Soedin. 1991, 1205–1208; Chem. Heterocycl. Comp. 1991,
27, 966–969.
3. The parent 3 and its protected derivatives are a versatile building
block for the construction of five-membered diazacycles. For repre-
sentative synthetic applications, see: (a) Yu, C.-Y.; Yang, P.-H.;
Zhao, M.-X.; Huang, Z.-T. Synlett 2006, 1835–1840; (b) Jones, R. C.
F.; Patel, P.; Hirst, S. C.; Smallridge, M. J. Tetrahedron 1998, 54,
6191–6200; (c) Jones, R. C. F.; Turner, I.; Howard, K. J. Tetrahedron
Lett. 1993, 34, 6329–6332; (d) Jones, R. C. F.; Hirst, S. C. Tetrahedron
Lett. 1989, 30, 5361–5364; (e) Jones, R. C. F.; Hirst, S. C. Tetrahedron
Lett. 1989, 30, 5365–5368; (f) Jones, R. C. F.; Smallridge, M. J.
Tetrahedron Lett. 1988, 29, 5005–5008.
The reaction course shown in Scheme 3 suggests that the
second nucleophilic addition (i.e., from 28 to 29) might be
feasible with other heteroatom functional groups. This
expectation was realized when N-tosylated aminoalcohol
33 entered the reaction to produce oxazolidine derivative
34 in excellent yield as a single isomer (Scheme 4).9 Its
Ts
N
NHTs
CONR
2
K PO
3
4
Br
CONR
+
2
NHX
NX
(27)
(28)
X = Ts or Boc
4. For mono-protected form of 3, see: Ref. 3. For other preparations of
derivatives of 3, see: (a) Shubina, Y. V.; Tikhomirov, D. A.; Eremeev,
A. V. Khim. Geterotsikl. Soedin. 1985, 618–622; Chem. Heterocycl.
Comp. 1985, 21, 516–520; (b) Wang, H.-T.; Wang, X.-J.; Huang, Z.-T.
Chem. Ber. 1990, 123, 2141–2145; (c) Dannhardt, G.; Laufer, S.;
Ziereis, K. Arch. Pharm. 1988, 321, 429–430; (d) Huang, Z.-T.; Tzai,
L.-H. Chem. Ber. 1986, 119, 2208–2219; (e) Anderson, M. W.; Begley,
M. J.; Jones, R. C. F.; Saunders, J. J. Chem. Soc., Perkin Trans. 1
1984, 2599–2602. For mono-protection of relevant ketones, see: (g)
Wang, M.-X.; Wu, X.-D.; Wang, L.-B.; Huang, Z.-T. Synth.
Commun. 1995, 25, 343–349; (h) Wang, M.-X.; Huang, Z.-T. J.
Org. Chem. 1995, 60, 2807–2811; (i) Ren, Z.-X.; Li, Z.-J.; Huang,
Z.-T. Synth. Commun. 1998, 28, 4241–4247.
Ts
N
Ts
N
Ts
N
O
NR
O
2
N
X
N
X
N
X
NR
NR
2
2
O
(29)
(30)
(31)
Ts
N
Ts
N
E
(X = Boc)
CONR
+
2
H
N
X
N
X
CONR
2
5. For structural confirmation, product 15 was reduced with Dibal to
give allylic alcohol 35, which was consistent with the expected
structure by 1H NMR analysis.
(32)
none
Scheme 3.